Towa Pharmaceutical Co., Ltd. Overview
Pro stress-test →Towa Pharmaceutical manufactures and sells ethical drugs in Japan, offering products in therapeutic areas including digestive system, nervous system, allergic diseases, vitamins, antibiotics, and oncology. The company expanded internationally in 2020 and now operates in more than 40 countries.
Strategic Profile
Pro stress-test →Towa is primarily positioned as a generic drug manufacturer, involved in the sale and outsourced manufacture of pharmaceuticals and generic drugs. The company demonstrates a defensive healthcare business profile with five-year annualized earnings growth of 8.3% and 11.2% one-year earnings growth.
Competitive Landscape
Pro stress-test →Towa underperformed the Japanese pharmaceuticals industry, which returned 25.6% over the past year. The company competes in the generic drug segment in Japan alongside larger integrated pharma firms and specialized generics manufacturers, with growing international competition from its expanded overseas operations.
Industry Context
Towa Pharmaceutical Co., Ltd. operates in Pharmaceuticals - Generic Drugs & Ethical Drug Manufacturing.
Key facts
Founded: 1951 · Headquarters: Osaka, Japan · Employees: 5,555 · Revenue: ¥269.9 billion · Market cap: ¥183.4 billion (~$1.2B USD)